The Weill Cornell Medicine Lymphoma Program seeks to enable people with lymphoma to have the best possible clinical outcome. fb.com/weillcornelllymphoma
Dr. @HBesien’s #research focuses on growing the most effective Epstein-Barr virus-specific T cells (EBV-CTLs) with the long-term goal of expanding this promising therapy to more patients with EBV-related #Lymphomas.
We're thrilled to officially announce the 2026 class of Conquer Cancer Grants and Awards recipients! 🔬 These grants empower the next generation of physician-scientists to turn innovative ideas into clinical breakthroughs. Congratulations to the new class—see you in Chicago for #ASCO26!
Full list of recipients here: bit.ly/4x0qpBF#ResearchConquersCancer#ConquerCancer@ASCO
A new @WeillCornell#CancerCast episode with @DrPinkalDesai just dropped. Hear about how we can now find common aging-related mutations(#CHIP#Blood) in the blood that are linked to cancer, inflammation, cardiovascular disease and other health risks bit.ly/4nIJbcl
Join members of our #BloodCancer team for a #CME symposium hosted by @nyphospital and @WCM_MeyerCancer on improving the diagnosis, treatment and referral pathways for patients with blood cancers in Brooklyn. Learn more and register: bit.ly/4tKkvlf
WATCH: Dr. Erin Mulvey discusses the changing treatment landscape for Richter Transformation, a rare condition where chronic lymphocytic leukemia (#CLL) or small lymphocytic #Lymphoma (SLL) turns into a more aggressive form of lymphoma bit.ly/4cKkW9P
#Research led by Dr. Jia Ruan and her collaborators aims to improve therapy options and survival rates for peripheral T-cell #Lymphoma. Hear more from Dr. Ruan about this important work: bit.ly/4dRoF6D
Dr. Erin Mulvey spoke with @Blood_Cancers about how the phase 3 MURANO #ClinicalTrial continues to inform targeted treatment approaches and management for chronic lymphocytic leukemia (#CLL): bit.ly/4tdHEg7
Watch Dr. Richard Furman discuss early findings from the CLL-17 #ClinicalTrial looking at different treatment regimens for untreated chronic lymphocytic leukemia (#CLL): bit.ly/4v4CDs3 (cc: @OncLearnNetwork)
Dr. Jia Ruan led research evaluating triplet combination therapy for previously untreated mantle cell #Lymphoma (MCL). She spoke with @OncLive about the key takeaways: bit.ly/3PsJ9Iz (cc: @BloodPortfolio)
Dr. Jia Ruan led research evaluating triplet combination therapy for previously untreated mantle cell #Lymphoma (MCL). She spoke with @OncLive about the key takeaways: bit.ly/3PsJ9Iz (cc: @BloodPortfolio)
Watch Dr. John Allan discuss strategies for treating relapsed or refractory chronic lymphocytic leukemia (CLL), including sequencing considerations: bit.ly/46Ra1If (cc: @medscape)
Dr. Jia Ruan presented at the @lymphoma Mantle Cell Lymphoma Scientific Consortium and Workshop on a phase 2 #ClinicalTrial of a combination therapy for patients with treatment-naive mantle cell #lymphoma. Learn more: bit.ly/4rRz8T2 (cc: @CancerNetwrk)
Dr. John Allan provided expert commentary on #research presented at #ASH25 evaluating a BTK inhibitor exclusively in treatment-naive patients with chronic lymphocytic leukemia (CLL)/small lymphocytic #lymphoma (SLL): bit.ly/4tvQ8A9
Dr. John Allan is speaking at Lymphoma Talk: New York, an in-person program on 3/5 hosted by @lymphoma where #lymphoma experts share information with patients about all forms of the disease. Register here: bit.ly/4bTU738
Join Dr. Erin Mulvey this afternoon for the Ask the Doctor About #Lymphoma series hosted by @lymphoma where she’ll be discussing how to navigate relapsed/refractory disease and answering live questions. Learn more and register: bit.ly/3ZvhCrV